Dristan

Dristan is an American consumer-health brand associated primarily with over-the-counter nasal decongestants and cold-relief medicines. The brand is made by Foundation Consumer Brands. Its best-known product is Dristan 12-Hour Nasal Spray, a topical nasal decongestant formulated with oxymetazoline hydrochloride at a concentration of 0.05%. The product is intended to provide extended relief from nasal congestion and belongs to the category of nonprescription medicines used for common cold, sinus, and allergy-related congestion. Dristan also markets combination cold products, including Dristan Cold Multi-Symptom Tablets. These tablets combine acetaminophen, chlorpheniramine maleate, and phenylephrine hydrochloride. The formulation is designed to address several cold symptoms at once: acetaminophen serves as a pain reliever and fever reducer, chlorpheniramine maleate is an antihistamine, and phenylephrine hydrochloride is a nasal decongestant. The product therefore occupies a broader cold-and-flu relief position than the brand's single-purpose nasal spray. The available reference material identifies Dristan as an American brand rather than a Canadian one. It does not provide a founding year, founder, headquarters, historical ownership timeline, financial information, or a detailed account of advertising campaigns. The brand's public identity is consequently best understood through its product portfolio: accessible, nonprescription symptom relief for nasal congestion and multiple common-cold symptoms. Its positioning depends on familiar pharmacy-channel formats, including nasal spray and oral tablets, and on functional claims centered on decongestion, symptom reduction, and duration of relief. Dristan's current brand scope, based on the available information, remains concentrated in consumer healthcare rather than cosmetics or general beauty products. Because the source material is brief, additional details about geographic distribution, product variants, regulatory history, packaging changes, and present-day retail availability require verification.

The available historical record for Dristan is limited. The brand is described as an American medication brand made by Foundation Consumer Brands. Unlike a diversified corporate group, Dristan is presented primarily as a consumer-facing product name within the over-the-counter medicines sector. Dristan's identifiable product history is centered on two types of treatment. The first is a long-duration nasal spray: Dristan 12-Hour Nasal Spray uses oxymetazoline hydrochloride 0.05% as its active ingredient. Oxymetazoline is a topical nasal decongestant, and the product's name emphasizes the intended duration of relief. This offering gives the brand a focused role in treating nasal congestion through a spray format. The second is a combination oral medicine, Dristan Cold Multi-Symptom Tablets. The listed formulation contains acetaminophen 325 mg, chlorpheniramine maleate 2 mg, and phenylephrine hydrochloride 5 mg. These ingredients correspond to different symptom categories: acetaminophen addresses pain and fever, chlorpheniramine is an antihistamine, and phenylephrine is used as a nasal decongestant. The combination reflects a common consumer-health strategy of grouping several cold symptoms into a single product. Together, these products indicate a portfolio organized around convenience and symptom-specific or multi-symptom relief. The nasal spray targets congestion directly, while the tablets provide a broader cold-relief proposition. The available sources do not establish when Dristan was founded, identify its original creator, document prior owners, or explain the circumstances under which Foundation Consumer Brands became its manufacturer. They also do not provide reliable details on advertising history, international expansion, sales, financial performance, clinical controversies, recalls, litigation, or major corporate transactions. The supplied country field identifies Canada, but the authoritative reference describes Dristan as an American brand. The subject should therefore be classified as United States-based in this dossier, while the exact headquarters and market footprint remain unconfirmed. More extensive historical claims would require additional primary or authoritative secondary sources.

An over-the-counter consumer-health brand offering practical relief for nasal congestion and common cold symptoms, with products spanning targeted nasal sprays and multi-symptom oral medicines.

• Dristan 12-Hour Nasal SprayNasal decongestant

  A nasal decongestant spray containing oxymetazoline hydrochloride 0.05% as its active ingredient. The product is positioned for extended relief of nasal congestion and represents Dristan's focused, topical treatment format.

• Dristan Cold Multi-Symptom TabletsMulti-symptom cold medicine

  An oral cold-relief product containing acetaminophen 325 mg, chlorpheniramine maleate 2 mg, and phenylephrine hydrochloride 5 mg. The combination is intended to address pain and fever, allergy-like symptoms, and nasal congestion within one tablet product.

1. Dristan